Related Experiment Video
Updated: Feb 28, 2026
10:17
The Tail Suspension Test
Published on: January 28, 2012
83.7K
Genomics of Lithium Action and Response
1Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow, G4 0RE, UK. benjamin.pickard@strath.ac.uk.
Summary
Lithium is a key mood stabilizer for bipolar disorder, but its broad actions and varied patient responses are complex. Research is uncovering genetic factors to personalize lithium treatment for better outcomes and fewer side effects.
Area of Science:
- Psychiatry and Pharmacology
- Genetics and Genomics
- Molecular Biology
Background:
- Lithium is the primary mood stabilizer for bipolar disorder, yet its precise mechanisms remain incompletely understood.
- Unlike targeted drugs, lithium affects numerous biological pathways, leading to variable treatment responses and side effect profiles.
- Individual genetic variations significantly influence both lithium efficacy and susceptibility to adverse effects.
Purpose of the Study:
- To review recent advances in understanding the genetic underpinnings of lithium's therapeutic actions and side effects in bipolar disorder.
- To explore how transcriptomic, genomic, and cell-model research contributes to defining lithium's biological mechanisms.
- To discuss the potential for genetically informed, personalized lithium prescription.
Main Methods:
- Summary and discussion of recent findings from genome-wide association studies (GWAS).
- Analysis of research utilizing patient-derived cell lines to model lithium's effects.
- Integration of genetic and transcriptomic data to identify key biological pathways.
Main Results:
- Progress has been made in identifying genetic factors associated with lithium response and toxicity.
- Cell-model studies are elucidating specific molecular pathways influenced by lithium.
- Evidence suggests that genetic variations play a crucial role in mediating lithium's complex effects.
Conclusions:
- Genuine progress is being made to define clinically useful mechanisms of lithium treatment.
- Understanding the interplay between genetics and lithium action is vital for contextualizing bipolar disorder pathology.
- Future research aims to enable targeted lithium prescription for individuals most likely to benefit.
Related Concept Videos
01:28Human Genetics
1.7K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.7K
01:29Pharmacogenetics and Pharmacogenomics: Overview
74
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
74
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
63
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
63
01:24Mania and Antimanic Drugs: Overview
708
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
708
01:29Pharmacogenomics: Identification of New Drug Targets
53
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
53
01:27Principles of Pharmacogenetics: Types of Genetic Variants
59
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
59